Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $289000.0.

  • Corcept Therapeutics' Depreciation & Amortization (CF) fell 911.95% to $289000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 5673.08%. This contributed to the annual value of $795000.0 for FY2024, which is 2370.44% down from last year.
  • Per Corcept Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $289000.0 for Q3 2025, which was down 911.95% from $286000.0 recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Depreciation & Amortization (CF) ranged from a high of $2.2 million in Q2 2021 and a low of -$1.7 million during Q3 2021
  • In the last 5 years, Corcept Therapeutics' Depreciation & Amortization (CF) had a median value of $281000.0 in 2024 and averaged $264631.6.
  • Within the past 5 years, the most significant YoY rise in Corcept Therapeutics' Depreciation & Amortization (CF) was 168790.32% (2021), while the steepest drop was 208588.24% (2021).
  • Over the past 5 years, Corcept Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $289000.0 in 2021, then skyrocketed by 128.37% to $660000.0 in 2022, then plummeted by 67.58% to $214000.0 in 2023, then skyrocketed by 31.31% to $281000.0 in 2024, then rose by 2.85% to $289000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $289000.0 for Q3 2025, versus $286000.0 for Q2 2025 and $285000.0 for Q1 2025.